Revenue and gross profit not reported for QQ3 2025 (no revenue disclosed in the quarter).
Key expense and profitability metrics (USD, in thousands):
- Research and Development (R&D): 48,004.0
- Selling, General & Administrative (SG&A): 18,015.0
- Total operating expenses: 66,019.0
- EBITDA: -66,019.0
- Operating income: -66,019.0
- Total interest expense: 1,978.0
- Depreciation & amortization: 1,000.0
- Income before tax: -65,765.0
- Income tax expense: 575.0
- Net income: -66,340.0
- Earnings per share (diluted): -0.79
- Weighted average shares outstanding: 83.499 million
Cash flow and balance sheet (USD, in thousands):
- Net cash provided by operating activities: -50,713.0
- Purchases of property, plant and equipment: -1,800.0
- Purchases of investments: -137,020.0
- Sales/maturities of investments: 92,500.0
- Net cash used in investing activities: -46,320.0
- Net cash provided by (used in) financing activities: 155,930.0
- Net change in cash: 58,746.0
- Cash at end of period: 173,945.0
- Cash and cash equivalents: 172,245.0
- Short-term investments: 364,294.0
- Cash and short-term investments: 536,539.0
- Total assets: 603,628.0
- Total liabilities: 121,254.0
- Total stockholders’ equity: 482,374.0
- Net debt position: -96,204.0 (net cash)
Liquidity and leverage metrics:
- Current ratio: 11.43; Quick ratio: 11.43; Cash ratio: 3.60
- Total debt: 76,041.0; Long-term debt: 72,098.0; Net debt: -96,204.0 (net cash)
- Price/earnings (NTM) and EV metrics show negative earnings backdrop (e.g., Enterprise Value Multiple: -13.86; Price to Earnings: negative)
YoY and QoQ performance (where available):
- Operating income YoY: -16.77%; QoQ: -12.06%
- Net income YoY: -29.77%; QoQ: -25.04%
- EPS YoY: -2.60%; QoQ: -16.18%